CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seven Bridges, the biomedical data analysis company, today announced that its senior scientists and collaborators will lead several sessions at Boston’s Festival of Genomics, to be held June 27-29 at the Boston Convention Center.
The program includes a Seven Bridges plenary session on precision medicine and a workshop providing a hands-on experience with the Cancer Genomics Cloud (CGC), a pilot system funded by the National Cancer Institute and powered by Seven Bridges. A third session will feature Dr. Brian O’Connor, Technical Director of the UCSC Genomics Institute, discussing the cloud-based infrastructure for the PanCancer Analysis of Whole Genomes (PCAWG) project.
“Cloud technology is opening the door to unprecedented levels of collaboration and scale when it comes to genomics research,” said James Sietstra, President of Seven Bridges. “We look forward to giving Festival of Genomics participants the opportunity to learn more about population-scale genomics projects, dive into the rich data on the CGC, and explore how these advance our understanding of cancer.”
Details on the sessions are as follows:
Cancer genomics at petabyte scale: Introduction to the Cancer Genomics Cloud for scalable, collaborative and reproducible analysis of TCGA data and more
|WHO:||Gaurav Kaushik, Ph.D., Scientific Program Manager, Seven Bridges|
|Jack DiGiovanna, Ph.D., Scientific Program Manager, Seven Bridges|
|WHEN:||Monday, June 27, 12:30 p.m. ET|
|WHY:||The CGC makes more than a petabyte of multidimensional data available to authorized researchers, enabling them to collaborate and analyze massive genomics datasets, like The Cancer Genome Atlas (TCGA). This workshop will give participants the opportunity to build and deploy workflows to analyze large data sets. Attendees will learn how to use visual and programmatic interfaces to analyze their own data on the CGC (either alone or in conjunction with TCGA data), how to customize workflows, automate and scale analyses to hundreds of executions, and more.|
ENABLING DATA SESSION
Large-scale, cloud-based analysis of cancer genomes: lessons learned from the PanCancer Analysis of Whole Genomes (PCAWG) project.
|WHO:||Dr. Brian O’Connor, Technical Director of the UCSC Genomics Institute|
|WHEN:||Tuesday, June 28, 12:00 p.m. ET|
|WHY:||Dr. Brian O’Connor will discuss the cloud-based infrastructure and lessons learned for the PanCancer Analysis of Whole Genomes (PCAWG) project. The largest and most complete investigation of the molecular mechanisms that contribute to cancer, this project was made possible by the collaboration of hundreds of researchers and organizations worldwide, including Seven Bridges.|
Precision Medicine in the Million Genome Era
|WHO:||Jack DiGiovanna, Ph.D., Scientific Program Manager, Seven Bridges|
|WHEN:||Wednesday, June 29, 9:40 a.m. ET|
|WHY:||Researchers around the world are working on building population-scale genome–phenome comparisons to accelerate precision medicine. Dr DiGiovanna will discuss how some of the largest such projects in the world are actually getting done, including the US Department of Veterans Affairs Million Veteran Program and Genomics England’s 100,000 Genomes Project.|
The Festival of Genomics features a wide range of presentations and in-depth workshops focused on the latest advances in genomic research, technology and medicine. Gaurav Kaushik and Jack DiGiovanna of Seven Bridges will join participants from academic and research institutions such Harvard Medical School, The Broad Institute, Tufts University School of Medicine, hospitals, pharmaceutical and biotech companies and more to exchange ideas and share new developments in genomics. Attendees can also check out demos of the Seven Bridges Platform at the company’s booth (#426). Complete information on the various sessions at Festival of Genomics can be found here.
About Seven Bridges
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset. The company has offices in Cambridge, Mass., Belgrade, London and San Francisco.